Pharmacogenomics

Genomics|Update|Current

Pharmacogenomics

A question-based approach to adopting pharmacogenetics to understand risk for clinical variability in pharmacokinetics in early drug development 
Evers R, et al. Clin Pharmacol Ther 2014 Sep;96(3):291-5

Clinical evidence supporting pharmacogenomic biomarker testing provided in US Food and Drug Administration drug labels 
Wang B, et al. JAMA Intern Med 2014 Oct

Direct-to-consumer pharmacogenomic testing is associated with increased physician utilisation.
Bloss CS, et al. J Med Genet. 2014 Feb;51(2):83-9.

Direct-to-consumer pharmacogenomic testing assessed in a US-based study  [PDF 162.03 KB] 
Daly A J R Coll Physicians Edinb 2014 Sep;44(3):212-3

Pharmacogenomics of statin therapy: any new insights in efficacy or safety? 
Hopewell, Jemma C.; Reith, Christina; Armitage, Jane. Current Opinion in Lipidology, October 13, 2014

Pharmacogenetic-guided psychiatric intervention associated with increased adherence and cost savings 
Fagerness J, et al. Am J Manag Care 2014 May;20(5):e146-56